Intracerebroventricular interleukin-6 treatment decreases body fat in rats

Biochemical and Biophysical Research Communications

Volumn 293, Issue 1, 2002, Pages 560-565

  Wallenius, Kristina ^a   Wallenius, Ville ^a   Sunter, David ^b   Dickson, Suzanne L ^b   Jansson, John Olov ^a  

^a SAHLGRENSKA UNIVERSITY HOSPITAL   (Sweden)

^b UNIVERSITY OF CAMBRIDGE   (United Kingdom)

Author keywords

Adipose tissue; IL 6; Intracerebroventricular; Leptin

Indexed keywords

ACUTE PHASE PROTEIN; HAPTOGLOBIN; INSULIN; INTERLEUKIN 6; LEPTIN; SODIUM CHLORIDE; SOMATOMEDIN C;

ADIPOSE TISSUE; ADRENAL GLAND; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BODY FAT; BODY MASS; BODY WEIGHT; CONTROLLED STUDY; DRUG EFFECT; FOOD INTAKE; HEART WEIGHT; INSULIN BLOOD LEVEL; KIDNEY MASS; KNOCKOUT MOUSE; LIPID DIET; LIVER WEIGHT; MALE; NONHUMAN; ORGAN WEIGHT; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; RAT; SPLEEN WEIGHT;

ADIPOSE TISSUE; ANIMALS; BODY WEIGHT; ENERGY INTAKE; HAPTOGLOBINS; INJECTIONS, INTRAVENTRICULAR; INTERLEUKIN-6; LIVER; MALE; MICE; MICE, KNOCKOUT; OBESITY; ORGAN SIZE; RATS; RATS, WISTAR;

EID: 0036295573     PISSN: 0006291X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-291X(02)00230-9     Document Type: Article

References (35)

1. Obesity as a medical problem
2. Hypothalamic control of feeding
3. Leptin and the regulation of body weight in mammals
4. Obesity and the hypothalamus: Novel peptides for new pathways
5. Physiological response to long-term peripheral and central leptin infusion in lean and obese mice
6. Interleukin-6-deficient mice develop mature-onset obesity
7. Interleukin-6: An overview
8. IL-6 is an antiinflammatory cytokine required for controlling local or systemic acute inflammatory responses
9. Subcutaneous adipose tissue releases interleukin-6, but not tumor necrosis factor-alpha, in vivo
10. Elevation of plasma cytokines in disorders of excessive daytime sleepiness: Role of sleep disturbance and obesity
11. The differential effect of food intake and beta-adrenergic stimulation on adipose-derived hormones and cytokines in man
12. Elevated levels of interleukin6 are reduced in serum and subcutaneous adipose tissue of obese women after weight loss
13. Pro- and anti-inflammatory cytokine balance in strenuous exercise in humans
14. Muscle contractions induce interleukin-6 mRNA production in rat skeletal muscles
15. Cellular localization of interleukin 6 mRNA and interleukin 6 receptor mRNA in rat brain
16. The expressions of mRNAs for interleukin-6 IL-6 and the IL-6 receptor IL-6R in the rat hypothalamus and midbrain during restraint stress
17. Interleukin-6 is a centrally acting endogenous pyrogen in the rat
18. Anorexia induced by activators of the signal transducer gp 130
19. Anorexia induced by chronic central administration of cytokines at estimated pathophysiological concentrations
20. The association of thirst, sodium appetite and vasopressin release with c-fos expression in the forebrain of the rat after intracerebroventricular injection of angiotensin II, angiotensin-(1-7) or carbachol
21. Central administration of rat IL-6 induces HPA activation and fever but not sickness behavior in rats
22. Obesity and the regulation of energy balance
23. Muscle undergoes atrophy in association with increase of lysosomal cathepsin activity in interleukin-6 transgenic mouse
24. Cytokines and cachexia
25. Reduced body fat and increased hepatic lipid synthesis in mice bearing interleukin-6-secreting tumor
26. Interleukin-6 secretion in mice is associated with reduced glucose-6-phosphatase and liver glycogen levels
27. Interleukin 6 causes growth impairment in transgenic mice through a decrease in insulin-like growth factor-I. A model for stunted growth in children with chronic inflammation
28. Leukemia inhibitory factor, Interleukin 6, and other cytokines using the GP130 transducing receptor: Roles in inflammation and injury
29. Interleukin 6 and its receptor: Ten years later
30. Ciliary neurotrophic factor activates leptin-like pathways and reduces body fat, without cachexia or rebound weight gain, even in leptin-resistant obesity
31. Ciliary neurotrophic factor corrects obesity and diabetes associated with leptin deficiency and resistance
32. Medicinal strategies in the treatment of obesity
33. Ciliary neurotrophic factor is catabolic and shares with IL-6 the capacity to induce an acute phase response
34. Omental and subcutaneous adipose tissues of obese subjects release interleukin-6: Depot difference and regulation by glucocorticoid
35. Immune and inflammatory responses in the CNS: Modulation by astrocytes